View in EDS HTML Full Text PDF Full Text

Ruxolitinib enhances gastric cancer to chemotherapy by suppressing JAK/STAT3 and inducing mitochondrial dysfunction and oxidative stress.

Saved in:
Bibliographic Details
Title: Ruxolitinib enhances gastric cancer to chemotherapy by suppressing JAK/STAT3 and inducing mitochondrial dysfunction and oxidative stress.
Authors: Yao, Yang1 (AUTHOR), Zhou, Jun1 (AUTHOR), Song, Jing1 (AUTHOR) songjing@hbuas.edu.cn, Chen, Cheng1 (AUTHOR) cccy496618301@163.com
Source: Immunopharmacology & Immunotoxicology. Apr2025, Vol. 47 Issue 2, p263-271. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:08923973
DOI:10.1080/08923973.2025.2470344